Aileron Therapeutics Inc. buy BiotechBee
Start price
10.10.22
/
50%
€0.21
Target price
31.12.24
€0.50
Performance (%)
-24.88%
End price
21.12.22
€0.16
Summary
This prediction ended on 21.12.22 with a price of €0.16. The price of Aileron Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -24.88%. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Aileron Therapeutics Inc. | - | - | - |
iShares Core DAX® | 1.560% | 2.566% | 18.261% |
iShares Nasdaq 100 | 0.517% | 1.894% | 25.521% |
iShares Nikkei 225® | 1.730% | 5.631% | 18.569% |
iShares S&P 500 | 1.482% | 1.594% | 24.989% |
According to BiotechBee what are the pros and cons of Aileron Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Aileron Therapeutics Inc. diskutieren
Buy mit Kursziel 0,5
In the thread Trading Aileron Therapeutics Inc.
Buy beendet
Stopped prediction by BiotechBee for Aileron Therapeutics Inc.
Aileron Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.16
04.01.23
04.01.23
€0.80
31.12.25
31.12.25
0.00%
06.02.23
06.02.23
Could be very worthwhile Investment >20% year